SB4

etanercept biosimilar · Samsung Bioepis Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for SB4, covering 2016-08-29 to 2019-06-04. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacokinetic, Safety, Tolerability and Immunogenicity Study of SB4 in Healthy Male Subjects [Phase 1]